Probiotics to prevent irregular heartbeat after cardioversion
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether taking probiotics (beneficial bacteria) can help prevent atrial fibrillation (an irregular heartbeat) from coming back after a procedure called cardioversion, which resets the heart's rhythm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older
- Your body mass index (BMI) is under 40
- You have persistent atrial fibrillation (irregular heartbeat) and have just had a cardioversion procedure
- You have not taken probiotics in the last 6 weeks
- You do not have an autoimmune disease, active infection, or are not on immunosuppressive therapy
- You are not pregnant or breastfeeding, and are not participating in another clinical study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding acupuncture can help prevent atrial fibrillation from coming back after a heart ablation procedure. It aims to lower the chance of irregular heartbeats in the months following treatment.
This study tests whether giving the medicine amiodarone before a scheduled electrical cardioversion (a procedure that shocks the heart back into rhythm) improves the chances of restoring a normal heartbeat in people with persistent atrial fibrillation. It compares outcomes with and without this pre-treatment.
This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.
This study looks at how a heart rhythm procedure (cardioversion) affects quality of life in people with persistent atrial fibrillation (AF). It may help you understand whether a specific approach can improve day-to-day symptoms and well-being after treatment.
This trial tests whether giving a medication right after a heart valve replacement can prevent a common type of irregular heartbeat (atrial fibrillation). It compares two medicines to see which is more effective.
This trial tests whether taking a cholesterol-lowering medicine called ezetimibe alongside the usual care can help prevent atrial fibrillation from coming back after a procedure called catheter ablation. Catheter ablation is a treatment that uses heat or cold to destroy tiny areas of heart tissue that cause irregular heartbeats. For people with persistent atrial fibrillation, this trial may offer a way to improve the long-term success of the ablation.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.